Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Digital Therapeutics Landscape in Europe

    September 3, 2020 |  

    OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

    Digital Therapeutics Landscape in Europe: The Case of Germany and the UK

    The COVID-19 virus crisis has opened immense windows of opportunity in healthcare around the globe. One of the greatest opportunities is in digital health, and in particular, digital therapeutics (DTx). The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide.1 As the interest in and use of digital health has grown during this period, we anticipate that investments in digital health tools will continue to accelerate after the COVID-19 pandemic. When the COVID-19 outbreak started, millions of Chinese people turned to online doctors and online health tools1 to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry 4.0 in healthcare for the benefit of patients.

    HIGHLIGHTS INCLUDE:
    • Opportunities and threats of digital therapeutics after COVID-19
    • Digital therapeutics landscape in the European Union
    • Review and comparison of the German and UK therapeutics landscape
    • Develop game-changing insights and competitive advantage on both a global and local scalepi

    Pink divider

    Download the white paper and learn how it’s happening now!

    Download the Paper- PMLiVE

    1. https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.html

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    How to pick the perfect training program for your healthcare professionals

    You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...

    Maximize your training investments with learning and development specialists

    Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can...

    A day in the life of a PR Account Director

    We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health

    OPEN Health acquires UK medical communications agency Spirit

    OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.

    OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021

    We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).

    Pharmerit rebrands to OPEN Health

    OPEN Health is moving to one brand to create a world-class integrated services model

    Established as many. United as one.

    Rare Disease Day 2021

    To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to...

    What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health

    If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...

    What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health

    How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify...